Overview

Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Systemic Lupus (SLE) is a chronic disease for which long term treatments are warranted. The aim of this study was to study the possibility of corticosteroids interruption in patients with quiescent SLE treated since at least one year with 5 milligrams of predonisone per day.
Phase:
Phase 3
Details
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Treatments:
Hydroxychloroquine
Prednisone